A different way to study frequency volume charts in patients with nocturia

Denys, Marie‐Astrid; Goessaert, An-Sofie; Dejaeghere, Brecht; Decalf, Veerle; Everaert, Karel

doi:10.1002/nau.23344

Cited by 3 publications

(3 citation statements)

References 16 publications

(40 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…19 Another factor in the classification of nocturia is its differentiation between continuous and fluctuating. 20 The NPi is thought to increase with fluid intake in both fluctuating and continuous nocturia, however, the latter pattern is further characterized by a lower maximum voided volume (MVV) (Table 3).…”

Section: Evaluation and Classification Of Nocturia And Npmentioning

confidence: 99%

Management of Nocturia and Nocturnal Polyuria

Weiss

Everaert

2019

Urology

Self Cite

View full text Add to dashboard Cite

Nocturnal polyuria (NP), characterized by overproduction of urine at night (greater than 20%-33% of total 24-hour urine volume depending on age), is a major contributing factor in most nocturia cases. Nocturia can be caused by intake, urological, nephrological, hormonal, sleep, and cardiovascular factors. It is therefore important to accurately diagnose both the type of nocturia and the potentially associated medical conditions to determine appropriate treatment. Diagnostic tools, in addition to a thorough history and physical examination, include voiding/bladder diary analyses and questionnaires to diagnose nocturia type (NP, diminished nocturnal/global bladder capacity, global polyuria) and causative factors. Lifestyle modifications are the first intervention implemented for the management of nocturia and NP but, as symptoms progress, such measures may be insufficient, and pharmacotherapy may be initiated. While drugs for benign prostatic hyperplasia and overactive bladder have demonstrated statistically significant reductions in nocturnal voids, patients often fail to achieve a clinically meaningful response. Antidiuretic treatment is warranted for patients with nocturia due to NP because, in many patients, it treats the underlying cause (ie, insufficient secretion of antidiuretic hormone arginine vasopressin) that leads to overproduction of urine at night and has been shown to provide statistically significant reductions in nocturnal voids. Desmopressin, a synthetic analog of arginine vasopressin, is the only antidiuretic treatment indicated specifically for nocturia due to NP. Overall, the pathophysiology of NP is complex and differs from that of other types of nocturia. A multidisciplinary approach is necessary to effectively diagnose and manage this bothersome condition. UROLOGY 133: 24−33, 2019.

show abstract

Section: Evaluation and Classification Of Nocturia And Npmentioning

confidence: 99%

Management of Nocturia and Nocturnal Polyuria

Weiss

Everaert

2019

Urology

Self Cite

View full text Add to dashboard Cite

show abstract

“…This showed an association of Hp1‐1 with global polyuria (attributed to its salt sensitivity leading to hypertension [not demonstrated with other subtypes]). Salt restriction may provide a treatment option for these patients (Abstract 7) …”

Section: Introductionmentioning

confidence: 99%

What was hot at the ICS meeting 2015

Hainsworth

Igualada-Martinez

Koch

et al. 2016

Neurourol. Urodynam.

View full text Add to dashboard Cite

“…Patients with nocturia will usually have a mismatch between nocturnal urine production and bladder storage. 9 Alternatively, they may have insomnia or sleep disturbance.…”

mentioning

confidence: 99%